Kowa, Kitasato Institute Team Up for Research of Infectious Disease Meds; Cepharanthine for COVID-19

March 24, 2021
Kowa said on March 22 that it has entered into a joint research deal with the Kitasato Institute for the development of new infectious disease treatments. The pair plans to carry out antibacterial drug research on Clostridioides difficile infection and...read more